pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,921 catalysts · 5,627 phase readout · 2,288 8k filing · 236 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 45 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 2 catalysts2026-10-29: 7 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,627
  • 8k filing2,288
  • earnings236
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04138277: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Sponsor: Amicus Therapeutics. Phase: PHASE3. Conditions: Pompe Disease (Late-onset)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

Sponsor: Virginia Polytechnic Institute and State University. Phase: PHASE3. Conditions: Perinatal Stroke, Hemiparesis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03998501: fMRI to Examine the Effect of CBTm to Increase Resiliency for PTSD

Sponsor: University of Manitoba. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT05923801: Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Depression

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06054230: Genomic Sequencing for Evaluation of Fetal Structural Anomalies

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Fetal Structural Anomalies

full page →ctgov ↗
›COMPLETEDphase readoutNCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Sponsor: iRenix Medical, Inc.. Phase: PHASE2. Conditions: Retinal Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07465328: Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints.

Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Sarcopenia, Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT02792465: A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

Sponsor: University Health Network, Toronto. Phase: PHASE1. Conditions: Advanced Solid Cancers, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07182565: Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

Sponsor: West China Hospital. Phase: PHASE1. Conditions: Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07216365: Caffeine Optimization for Oxygen Saturation Index in ELBW Infants

Sponsor: University of Rochester. Phase: PHASE2. Conditions: Neonatal Apnea, Infants

full page →ctgov ↗
›COMPLETEDphase readoutNCT05167565: Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05345171: Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

Sponsor: Ultragenyx Pharmaceutical Inc. Phase: PHASE3. Conditions: OTC Deficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

Sponsor: Integrative Research Laboratories AB. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05203471: Crossing the Divide: Piloting Integrated Care to Reduce Amputations Among Rural Patients With Diabetic Foot Ulcers

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Diabetic Foot, Diabetic Ulcer of Left Foot, Diabetic Ulcer of Right Foot, Amputation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07025083: Adaptation of the Family Check-Up Online

Sponsor: University of Oregon. Phase: NA. Conditions: Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07634341: Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.

Sponsor: Fayoum University. Phase: PHASE4. Conditions: Chronic Periodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT02444741: Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT04774354: POSSUM, P-POSSUM, Clinical Frailty Scale, Clinical Frailty Scale and Charlson's Comorbidity Index in Abdominal Surgery.

Sponsor: Ángel Becerra-Bolaños, MD PhD. Phase: . Conditions: Postoperative Complications

full page →ctgov ↗
›COMPLETEDphase readoutNCT06458205: Impact of Multi-Component Interventions on High-Risk COPD Smokers

Sponsor: Peking Union Medical College. Phase: NA. Conditions: Multimorbidity, Tobacco Use Cessation, Smoking Reduction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07278466: The COMParing App Support Strategies Study

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Anxiety

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07512466: Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations

Sponsor: Assiut University. Phase: NA. Conditions: Nasal Cavity and Paranasal Sinus Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06172166: Transdisciplinary Care for Young Adults With Type 1 Diabetes

Sponsor: Nemours Children's Clinic. Phase: NA. Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05744856: A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam

Sponsor: Thai Binh University of Medicine and Pharmacy. Phase: NA. Conditions: GDM

full page →ctgov ↗
›COMPLETEDphase readoutNCT04647422: Social Cognition and Executive Functions in Alcohol Use Disorders - Transverse Study

Sponsor: CHU de Reims. Phase: NA. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07589751: Biomaterials Exposed to Oral Environment: Which One is the Appropriate Option?

Sponsor: Pontificia Universidade Católica do Rio Grande do Sul. Phase: NA. Conditions: Tooth Extraction Site Healing, Alveolar Ridge Preservation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07517029: Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: IBS - Irritable Bowel Syndrome, Post Infection Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT05966129: A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)

Sponsor: Duke University. Phase: NA. Conditions: Acute Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07196631: Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

Sponsor: Liu Jiuhong. Phase: PHASE4. Conditions: Rebound Pain, Liposomal Bupivacaine

full page →ctgov ↗
›COMPLETEDphase readoutNCT07255937: PMCF Study of Debridement Pad

Sponsor: Advanced Medical Solutions Ltd.. Phase: NA. Conditions: Diabetic Ulcers, Venous Leg Ulcer, Arterial Leg Ulcer, Pressure Ulcer, Postoperative Wound Healing, Traumatic Wounds, Surgical Wounds, Burns and Scalds

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04973345: Terbutaline Sulfate in Adults With Asthma

Sponsor: Kanecia Obie Zimmerman. Phase: PHASE2. Conditions: Asthma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07326072: The Study of ENB With Ultra-thin Cryobiopsy in the Diagnosis of Peripheral Pulmonary Nodules

Sponsor: Beijing Chao Yang Hospital. Phase: NA. Conditions: Diagnosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05353257: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Sponsor: Shanghai Henlius Biotech. Phase: PHASE3. Conditions: Limited-Stage Small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07547657: Implementation Guided by aN Iterative, adapTivE Strategy - Induction of Labor

Sponsor: University of Michigan. Phase: NA. Conditions: Birth; Induced

full page →ctgov ↗
›TERMINATEDphase readoutNCT06280157: A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

Sponsor: Minervax ApS. Phase: . Conditions: Group B Streptococcus Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07691801: Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Primary Aldosteronism

full page →ctgov ↗
›COMPLETEDphase readoutNCT06307301: Study in ALS With Abatacept & IL-2

Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07219381: Holistic Medicine Treatment of Uterine Fibroids-Adults

Sponsor: Virtual Tribunal Monastery. Phase: NA. Conditions: Uterine Fibroids - 1St Diagnosis, Uterine Fibroids Affecting Pregnancy, Uterine Fibroid Degenerated

full page →ctgov ↗
›COMPLETEDphase readoutNCT04498481: TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07527481: Nortriptyline and the Risk of Serious Adverse Events

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05934019: Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)

Sponsor: University of Bern. Phase: NA. Conditions: Mental Health Issue, Transdiagnostic Mechanisms, Adolescent Psychology, Prevention, Online Intervention, Psychological Intervention, Mental Disorder in Adolescence, Subclinical

full page →ctgov ↗
›COMPLETEDphase readoutNCT07456319: Sustainable Insect-based Protein Supplement in the Elderly: a Pilot Study

Sponsor: Universitat Oberta de Catalunya. Phase: NA. Conditions: Aging, Nutrition, Sustainable Diets, Cardiometabolic Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT05363319: An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

Sponsor: Regeneron Pharmaceuticals. Phase: . Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07380230: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

Sponsor: LI FENG. Phase: NA. Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07321730: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06806228: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

Sponsor: Petrov, Andrey. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Gliosarcoma, Giant Cell Glioblastoma, GBM

full page →ctgov ↗
›COMPLETEDphase readoutNCT04699630: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Sponsor: SCRI Development Innovations, LLC. Phase: PHASE2. Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07493928: HPV After chemoRadioTherapy

Sponsor: General University Hospital, Prague. Phase: . Conditions: Cervical Cancer Recurrent, Radiotherapy, Cell Free DNA, HPV

full page →ctgov ↗
›COMPLETEDphase readoutNCT00898365: Study of Kidney Tumors in Younger Patients

Sponsor: Children's Oncology Group. Phase: . Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT00156767: Adrenal Function in Critical Illness

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Adrenal Insufficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07393867: Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Sponsor: Martin T. King, MD, PhD. Phase: PHASE2. Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer

full page →ctgov ↗
← prev
page 122 of 159
next →